Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

PrideRx vs RestorLife Med

PrideRx
Graded #434

Lower grade

vs+9.599999999999994
RestorLife Med
Graded #222

Higher grade

The verdict

RestorLife Med takes it — 65.3/100 to 55.7/100.

RestorLife Med grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. RestorLife Med is a physician-guided GLP-1 telehealth practice (founder Dr.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRestorLife Med +24
20
44
Dose & formulationPrideRx +31
83
52
Clinical oversightRestorLife Med +23
74
97
Labs & monitoringRestorLife Med +13
53
66
FulfillmentRestorLife Med +30
67
97
Contract termsPrideRx +4
41
37
PrideRx · left barRestorLife Med · right bar

The numbers

MetricPrideRxRestorLife Med
WeighScore55.7/10065.3/100
GradeCC
Scorecard rank#434#222
Semaglutide$149/mo (starting dose, plus a separate fee, brand-name)$199/mo (6-month plan, compounded)
Tirzepatide$299/mo (2.5 mg dose, plus a separate fee, brand-name)Not disclosed
CoverageCoverage not publishedAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
PrideRx

Graded #434 · C

Strengths

  • All three brand-name GLP-1 options on one platform — Zepbound injection, Wegovy Pill, and Foundayo — no compounded substitutes
  • Medication ships from and is billed by LillyDirect or NovoCare; PrideRx never handles or re-sells the drug
  • Transparent published per-dose pricing with on-page verification dates
  • $99/mo membership includes doctor visits and prescription management; 24-hour prescription review

Where it loses points

  • $99/mo membership on top of medication cost — all-in runs $248–$548/mo depending on drug and dose
  • Legal entity and prescribing medical group are not named on the site
  • No LegitScript certification visible
  • State availability is not published — telehealth consult rules vary by state
RestorLife Med

Graded #222 · C

Strengths

  • Verifiable LegitScript certification (seal ID 50400451) plus a named board-certified physician (Dr. Michael Wasef, MD) licensed in all 50 states
  • Full GLP-1 lineup: compounded semaglutide and tirzepatide, plus gentler microdose entry options
  • Generous support — unlimited care-team messaging, monthly check-ins, dosage adjustments, and 1 free blood test per quarter on the GLP-1 protocols
  • Available in all 50 states with free priority shipping, discreet packaging, and roughly 48-hour delivery
  • Transparent multi-month pricing with 50% off your first month; semaglutide protocols are compounded with B12

Where it loses points

  • The advertised $299 is a struck-through anchor price, not a starting point: the real month-to-month rate is $299, a first month runs $149 at 50% off, and the $199 rate needs six months
  • The page states its pricing is 'introductory and subject to change', so none of these figures is committed to
  • The tirzepatide price is published the same way, against a struck-through anchor, and we could not establish which figure a buyer actually pays
  • A separate semaglutide microdose is sold at $99/mo — a sub-therapeutic protocol, not a cheaper weight-loss dose
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard